DGX

SEC source: 0001022079-25-000126 · wk-form4_1746217832.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,246

F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 15

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 127,623

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F16 · price: This transaction was executed in multiple trades at prices ranging from $169.4242 to $169.8209. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 14

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,076

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F15 · price: This transaction was executed in multiple trades at prices ranging from $168.424 to $169.4178. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 13

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,978

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F14 · price: This transaction was executed in multiple trades at prices ranging from $167.420 to $168.4134. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 12

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130,471

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F13 · price: This transaction was executed in multiple trades at prices ranging from $169.3491 to $169.830. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 11

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 130,738

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F12 · price: This transaction was executed in multiple trades at prices ranging from $168.3348 to $169.3269. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 10

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 131,322

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F11 · price: This transaction was executed in multiple trades at prices ranging from $167.3341 to $168.334. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 9

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 132,072

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F10 · price: This transaction was executed in multiple trades at prices ranging from $169.400 to $169.770. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 8

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 134,565

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F9 · price: This transaction was executed in multiple trades at prices ranging from $168.360 to $169.260. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 7

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 140,465

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F8 · price: This transaction was executed in multiple trades at prices ranging from $167.335 to $168.250. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 6

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 147,415

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F7 · price: This transaction was executed in multiple trades at prices ranging from $169.3418 to $169.8434. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 5

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 150,179

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F6 · price: This transaction was executed in multiple trades at prices ranging from $168.3337 to $169.3257. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 4

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 155,084

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F5 · price: This transaction was executed in multiple trades at prices ranging from $167.3326 to $168.3284. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 3

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 162,333

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F4 · price: This transaction was executed in multiple trades at prices ranging from $169.570 to $169.750. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 2

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 163,037

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F3 · price: This transaction was executed in multiple trades at prices ranging from $168.500 to $169.420. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-25-000109 · wk-form4_1743812984.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 164,448

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F2 · price: This transaction was executed in multiple trades at prices ranging from $167.420 to $168.405. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0001022079-25-000107 · wk-form4_1743812807.xml · nonDerivative · entry 1

KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,575

F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4.

SEC source: 0001022079-25-000105 · wk-form4_1743712825.xml · derivative · entry 1

Lassiter Wright III · CIK 0001805909 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 359.911

Underlying: Common Stock · 169 shares

Expires not disclosed

F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11.

SEC source: 0001022079-25-000103 · wk-form4_1743712741.xml · derivative · entry 1

RING TIMOTHY M · CIK 0001204666 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,409.562

Underlying: Common Stock · 251 shares

Expires not disclosed

F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.

F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11.

SEC source: 0001022079-25-000101 · wk-form4_1743194819.xml · nonDerivative · entry 1

Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,988

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000100 · wk-form4_1743194708.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,221

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000097 · wk-form4_1742432440.xml · nonDerivative · entry 1

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,117

F1 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

SEC source: 0001022079-25-000094 · wk-form4_1741393392.xml · nonDerivative · entry 1

Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,068

F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

SEC source: 0001022079-25-000092 · wk-form4_1741210704.xml · nonDerivative · entry 3

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,365

F3 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.

F4 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

SEC source: 0001022079-25-000092 · wk-form4_1741210704.xml · nonDerivative · entry 2

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,232

F2 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).

SEC source: 0001022079-25-000091 · wk-form4_1741210674.xml · nonDerivative · entry 4

Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,438

F4 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.

SEC source: 0001022079-25-000091 · wk-form4_1741210674.xml · nonDerivative · entry 3

Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 78,448

F3 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award approved in accordance with the requirements of Rule 16b-3(d).

SEC source: 0001022079-25-000091 · wk-form4_1741210674.xml · nonDerivative · entry 2

Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,068

F2 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

SEC source: 0001022079-25-000090 · wk-form4_1741210635.xml · nonDerivative · entry 3

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,814

F3 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock awards.

SEC source: 0001022079-25-000090 · wk-form4_1741210635.xml · nonDerivative · entry 2

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,470

F2 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock awards approved in accordance with the requirements of Rule 16b-3(d).

SEC source: 0001022079-25-000089 · wk-form4_1741210599.xml · nonDerivative · entry 3

KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,119

F3 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.

F4 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the reporting person's last filing on Form 4.

SEC source: 0001022079-25-000089 · wk-form4_1741210599.xml · nonDerivative · entry 2

KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,998

F2 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).

SEC source: 0001022079-25-000088 · wk-form4_1741210561.xml · nonDerivative · entry 3

Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,150

F3 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.

F4 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.

SEC source: 0001022079-25-000088 · wk-form4_1741210561.xml · nonDerivative · entry 2

Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,430

F2 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).

SEC source: 0001022079-25-000087 · wk-form4_1741210525.xml · nonDerivative · entry 4

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,760

F4 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.

SEC source: 0001022079-25-000087 · wk-form4_1741210525.xml · nonDerivative · entry 3

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 46,666

F3 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award dated approved in accordance with the requirements of Rule 16b-3(d).

SEC source: 0001022079-25-000087 · wk-form4_1741210525.xml · nonDerivative · entry 2

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,117

F2 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

SEC source: 0001022079-25-000086 · wk-form4_1741210490.xml · nonDerivative · entry 2

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,477

F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.

SEC source: 0001022079-25-000086 · wk-form4_1741210490.xml · nonDerivative · entry 1

DELANEY MARK E · CIK 0001955265 · SVP & Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,300

F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).

SEC source: 0001022079-25-000085 · wk-form4_1741210425.xml · nonDerivative · entry 2

SAMAD SAM · CIK 0001694295 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,377

F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.

SEC source: 0001022079-25-000085 · wk-form4_1741210425.xml · nonDerivative · entry 1

SAMAD SAM · CIK 0001694295 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,061

F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award approved in accordance with the requirements of Rule 16b-3(d).

SEC source: 0001022079-25-000092 · wk-form4_1741210704.xml · nonDerivative · entry 1

DEPPE MICHAEL J · CIK 0001771759 · SVP, Corp. Controller & CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,521

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000091 · wk-form4_1741210674.xml · nonDerivative · entry 1

Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,784

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000090 · wk-form4_1741210635.xml · nonDerivative · entry 1

Davis J. E. · CIK 0001599837 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 136,553

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000089 · wk-form4_1741210599.xml · nonDerivative · entry 1

KUPPUSAMY KARTHIK · CIK 0001955217 · SVP, Clinical Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,564

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000088 · wk-form4_1741210561.xml · nonDerivative · entry 1

Plewman Patrick · CIK 0001497368 · SVP for Diagnostic Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,756

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000087 · wk-form4_1741210525.xml · nonDerivative · entry 1

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 38,709

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

SEC source: 0001022079-25-000074 · wk-form4_1740778674.xml · nonDerivative · entry 2

PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,031

F2 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

SEC source: 0001022079-25-000071 · wk-form4_1740778491.xml · nonDerivative · entry 2

Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 69,178

F2 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

SEC source: 0001022079-25-000076 · wk-form4_1740778812.xml · nonDerivative · entry 1

SAMAD SAM · CIK 0001694295 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,177

F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.